These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 10980599

  • 1. Autoamplification of apoptosis following ligation of CD95-L, TRAIL and TNF-alpha.
    Herr I, Posovszky C, Di Marzio LD, Cifone MG, Boehler T, Debatin KM.
    Oncogene; 2000 Aug 31; 19(37):4255-62. PubMed ID: 10980599
    [Abstract] [Full Text] [Related]

  • 2. Induction of a TRAIL-mediated suicide program by interferon alpha in primary effusion lymphoma.
    Toomey NL, Deyev VV, Wood C, Boise LH, Scott D, Liu LH, Cabral L, Podack ER, Barber GN, Harrington WJ.
    Oncogene; 2001 Oct 25; 20(48):7029-40. PubMed ID: 11704827
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. NF-kappa B does not modulate sensitivity of renal carcinoma cells to TNF alpha-related apoptosis-inducing ligand (TRAIL).
    Pawlowski JE, Nesterov A, Scheinman RI, Johnson TR, Kraft AS.
    Anticancer Res; 2000 Oct 25; 20(6B):4243-55. PubMed ID: 11205254
    [Abstract] [Full Text] [Related]

  • 7. Death receptors and melanoma resistance to apoptosis.
    Ivanov VN, Bhoumik A, Ronai Z.
    Oncogene; 2003 May 19; 22(20):3152-61. PubMed ID: 12789291
    [Abstract] [Full Text] [Related]

  • 8. Mechanisms of resistance to TRAIL-induced apoptosis in cancer.
    Zhang L, Fang B.
    Cancer Gene Ther; 2005 Mar 19; 12(3):228-37. PubMed ID: 15550937
    [Abstract] [Full Text] [Related]

  • 9. High level of cFLIP correlates with resistance to death receptor-induced apoptosis in bladder carcinoma cells.
    Jönsson G, Paulie S, Grandien A.
    Anticancer Res; 2003 Mar 19; 23(2B):1213-8. PubMed ID: 12820373
    [Abstract] [Full Text] [Related]

  • 10. Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas.
    Herr I, Ucur E, Herzer K, Okouoyo S, Ridder R, Krammer PH, von Knebel Doeberitz M, Debatin KM.
    Cancer Res; 2003 Jun 15; 63(12):3112-20. PubMed ID: 12810637
    [Abstract] [Full Text] [Related]

  • 11. Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways.
    Suliman A, Lam A, Datta R, Srivastava RK.
    Oncogene; 2001 Apr 19; 20(17):2122-33. PubMed ID: 11360196
    [Abstract] [Full Text] [Related]

  • 12. Apo2 ligand/TNF-related apoptosis-inducing ligand and death receptor 5 mediate the apoptotic signaling induced by ionizing radiation in leukemic cells.
    Gong B, Almasan A.
    Cancer Res; 2000 Oct 15; 60(20):5754-60. PubMed ID: 11059770
    [Abstract] [Full Text] [Related]

  • 13. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling.
    Chen X, Kandasamy K, Srivastava RK.
    Cancer Res; 2003 Mar 01; 63(5):1059-66. PubMed ID: 12615723
    [Abstract] [Full Text] [Related]

  • 14. TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis in Fas ligand-resistant melanoma cells and mediates CD4 T cell killing of target cells.
    Thomas WD, Hersey P.
    J Immunol; 1998 Sep 01; 161(5):2195-200. PubMed ID: 9725211
    [Abstract] [Full Text] [Related]

  • 15. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
    Izeradjene K, Douglas L, Delaney A, Houghton JA.
    Clin Cancer Res; 2004 Oct 01; 10(19):6650-60. PubMed ID: 15475455
    [Abstract] [Full Text] [Related]

  • 16. Transcriptional regulation of VCAM-1 expression by tumor necrosis factor-alpha in human tracheal smooth muscle cells: involvement of MAPKs, NF-kappaB, p300, and histone acetylation.
    Lee CW, Lin WN, Lin CC, Luo SF, Wang JS, Pouyssegur J, Yang CM.
    J Cell Physiol; 2006 Apr 01; 207(1):174-86. PubMed ID: 16288471
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Critical roles for JNK, c-Jun, and Fas/FasL-Signaling in vitamin E analog-induced apoptosis in human prostate cancer cells.
    Jia L, Yu W, Wang P, Li J, Sanders BG, Kline K.
    Prostate; 2008 Mar 01; 68(4):427-41. PubMed ID: 18196534
    [Abstract] [Full Text] [Related]

  • 19. Active, phosphorylation-dependent MAP kinases, MAPK/ERK, SAPK/JNK and p38, and specific transcription factor substrates are differentially expressed following systemic administration of kainic acid to the adult rat.
    Ferrer I, Blanco R, Carmona M, Puig B, Domínguez I, Viñals F.
    Acta Neuropathol; 2002 Apr 01; 103(4):391-407. PubMed ID: 11904760
    [Abstract] [Full Text] [Related]

  • 20. Requirement of c-Jun NH2-terminal kinase activation in interferon-alpha-induced apoptosis through upregulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in Daudi B lymphoma cells.
    Yanase N, Hata K, Shimo K, Hayashida M, Evers BM, Mizuguchi J.
    Exp Cell Res; 2005 Oct 15; 310(1):10-21. PubMed ID: 16099454
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.